Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Change in Acquisitions & Divestments came in at $4.0 million in Q2 2026, up 300.0% year-over-year from $1.0 million in Q2 2025, and up 300.0% quarter-over-quarter from $1.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Change in Acquisitions & Divestments across 18 years of filings, most recently posting $4.0 million for Q2 2026.
- In Q2 2026, Change in Acquisitions & Divestments rose 300.0% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $8.0 million (down 33.33% YoY), while the FY2025 annual figure was $8.0 million, down 42.86% from the prior year.
- Change in Acquisitions & Divestments came in at $4.0 million for Q2 2026 at Bausch Health Companies, up from $1.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $13.0 million in Q4 2023 to a low of -$2.0 million in Q2 2023.
- Average Change in Acquisitions & Divestments over 5 years is $4.2 million, with a median of $4.0 million recorded in 2023.
- The largest YoY upside for Change in Acquisitions & Divestments was 550.0% in 2023 against a maximum downside of 128.57% in 2023.
- Over 5 years, Change in Acquisitions & Divestments stood at $2.0 million in 2022, then soared by 550.0% to $13.0 million in 2023, then plunged by 76.92% to $3.0 million in 2024, then slumped by 33.33% to $2.0 million in 2025, then soared by 100.0% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $4.0 million in Q2 2026, $1.0 million in Q1 2026, and $2.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 7.00 Mn |
| Jun 30, 2022 | 7.00 Mn |
| Mar 31, 2022 | 6.00 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 3.00 Mn |